mechanism 1,232 words KG: ent-gene-e0e233b2
Contents

CD33 Siglec Receptor Dysfunction Alzheimer's Disease Causal Chain

🔬 Protein Info
Gene Symbolent-gene-e0e233b2
V-type Ig-like domainSialic acid-binding capability
Two C2-type Ig-like domainsMediate protein-protein interactions
Cytoplasmic ITIMContains immunoreceptor tyrosine-based inhibition motifs (YXXL/V sequences)
Intracellular signalingRecruits phosphatases (SHP-1, SHP-2) that dephosphorylate signaling molecules
Microglial specificityCD33 is expressed almost exclusively on microglia in the brain
Age-dependent increaseCD33 expression increases with normal aging
AD-specific elevationFurther upregulated in AD brains, particularly around amyloid plaques[@walker2023]
Specific subtypesCD33+ microglia form a distinct population with reduced phagocytic capacity
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Related Hypotheses (48)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.77
Multi-Modal Stress Response Harmonization
Score: 0.76
Smartphone-Detected Motor Variability Correction
Score: 0.74
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.73
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.70
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.66
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
Ephrin-B2/EphB4 Axis Manipulation
Score: 0.64
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56
Blood-Brain Barrier SPM Shuttle System
Score: 0.53
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor
Score: 0.53
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.84
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
← Prevpg 2/3Next →

Related Analyses (30)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived

Related Experiments (30)

DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90

See Also (15)

ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Astrocyte-Derived Exosomal mRNA Reference Genes for Alz
biomarker · Pages share 18 hypotheses
AT(N) Biomarker Classification for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di
biomarker · Pages share 18 hypotheses
Blood p-Tau217 as a Clock for Alzheimer's Disease Onset
mechanism · Pages share 18 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)